Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Unlocking Hope with Improved Access to Gene Therapy
How a Health Care Supply Chain Officer Supports Patient Care
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
Unlocking Hope with Improved Access to Gene Therapy
The promise of CGTs is tempered by their staggering cost and treatment complexity.
How a Health Care Supply Chain Officer Supports Patient Care
Discover insights from a longtime children’s hospital supply chain leader on supporting patient care, community needs, and the health care supply chain.
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
A revolutionary therapy takes some children’s lives to new heights. Others are left out.
